What this determination covers
The Department of Health, Disability and Ageing has registered an amendment to the National Health (Originator Brand) Determination 2025, also known as PB 114 of 2025. The amendment is titled the National Health (Originator Brand) Amendment Determination (October Update) 2026 and was registered on 29 September 2026.
The determination operates under the National Health Act 1953 and governs rules about originator (branded) pharmaceutical products listed and subsidised under the Pharmaceutical Benefits Scheme (PBS).
What the amendment changes
The amendment makes changes to Schedule 1 of PB 114 of 2025. The source document does not specify which particular medicines or brands were added, removed, or repriced in this update.
Key actions
- View the full text of the amendment at https://www.legislation.gov.au/F2026L01322 to see the specific Schedule 1 changes to PB 114 of 2025.
- If your business dispenses or supplies PBS-listed originator brand medicines, check the amended determination to confirm whether any products you stock are affected.
- Set up an alert on the Federal Register of Legislation for future updates to this determination by using the Set up an alert function on the page at https://www.legislation.gov.au/F2026L01322.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.